M.BaranowskiR
02 Tissue Repair Peptide Research BPC-157 and TB-500 are individually among the most-studied peptides in connective tissue and musculoskeletal repair research
Currently, 13 states fully cover GLP-1s for obesity treatment under Medicaid, and legislative efforts continue to target expanded coverage
Our treatments effectively manage appetite and boost metabolism, making them an excellent choice for people who want a simple solution
A 2023 study published in the Journal of Clinical Endocrinology and Metabolism found that GLP-1 receptor agonist therapy in women with obesity and insulin resistance produced significant improvements in androgen levels, menstrual regularity, and metabolic markers, with effects most pronounced in women with baseline hyperinsulinemia, underscoring how tightly GLP-1 mechanisms are connected to broader hormonal function in women
In 2017, the FDA issued a warning about the dangers of using methylene blue in patients who take these medications
